Cite
Carnahan RM, Brown GD, Letuchy EM, et al. Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes. Alzheimers Dement (N Y). 2017;3(4):553-561doi: 10.1016/j.trci.2017.02.003.
Carnahan, R. M., Brown, G. D., Letuchy, E. M., Rubenstein, L. M., Gryzlak, B. M., Smith, M., Reist, J. C., Kelly, M. W., Schultz, S. K., Weckmann, M. T., & Chrischilles, E. A. (2017). Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes. Alzheimer's & dementia (New York, N. Y.), 3(4), 553-561. https://doi.org/10.1016/j.trci.2017.02.003
Carnahan, Ryan M, et al. "Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes." Alzheimer's & dementia (New York, N. Y.) vol. 3,4 (2017): 553-561. doi: https://doi.org/10.1016/j.trci.2017.02.003
Carnahan RM, Brown GD, Letuchy EM, Rubenstein LM, Gryzlak BM, Smith M, Reist JC, Kelly MW, Schultz SK, Weckmann MT, Chrischilles EA. Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes. Alzheimers Dement (N Y). 2017 Mar 06;3(4):553-561. doi: 10.1016/j.trci.2017.02.003. eCollection 2017 Nov. PMID: 29124114; PMCID: PMC5671632.
Copy
Download .nbib